X
1. 219921-94-5
2. Repaglinide Related Compound A
3. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetyl-l-glutamate
4. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine, N-acetyl-glutamate Salt
5. 1u5q8kd140
6. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate Salt
7. (2s)-2-acetamidopentanedioic Acid;(1s)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine
8. (1s)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine N-acetyl-l-glutamate
9. 3-methyl-1-(2-piperidinophenyl)-1-butylamine, (s)-, N-acetyl-l-glutamate
10. (1s)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine; (2s)-2-acetamidopentanedioic Acid
11. (s)-3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate
12. Mfcd09840998
13. Unii-1u5q8kd140
14. Dtxsid50176421
15. Bcp04251
16. Repaglinide Related Compound A [usp]
17. (s)-3-methyl-1-[2-(1-piperidinyl)phenyl]butylamine N-acetyl-l-glutamate Salt
18. Akos015919997
19. Ds-1077
20. (2s)-2-acetamidopentanedioic Acid,(1s)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine
21. Ac-23929
22. Repaglinide Related Compound A Rs [usp]
23. A25000
24. Ec 606-883-4
25. O10220
26. Repaglinide Related Compound A [usp-rs]
27. J-014399
28. Q27252888
29. Repaglinide Related Compound A [usp Impurity]
30. (s)-3-methyl-1-(2-piperidinophenyl)butylaminen-acetyl-l-glutamate
31. 3-methyl-1-(2-piperidinophenyl)butylamine N-acetylglutamate Salt
32. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine N-acetyl-glutamate Salt
33. (s,s')-3-methyl-1-(2-piperidinophenyl)butylamine,n-acetyl-glutamate Salt
34. N-acetyl-l-glutamate(s)-3-methyl-1-(2-piperidinophenyl)-1-butylamine
35. (2s)-2-acetamidopentanedioic Acid; (1s)-3-methyl-1-[2-(1-piperidyl)phenyl]butan-1-amine
36. (s)-3-methyl-1-(2-piperidine-1-phenyl)butylamine Compound With N-acetyl-l-glutamic Acid
37. L-glutamic Acid, N-acetyl-, Compd. With (.alpha.s)-.alpha.-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine (1:1)
38. L-glutamic Acid, N-acetyl-, Compd. With (alphas)-alpha-(2-methylpropyl)-2-(1-piperidinyl)benzenemethanamine (1:1)
| Molecular Weight | 435.6 g/mol |
|---|---|
| Molecular Formula | C23H37N3O5 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 9 |
| Exact Mass | 435.27332129 g/mol |
| Monoisotopic Mass | 435.27332129 g/mol |
| Topological Polar Surface Area | 133 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 458 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
List of Suppliers
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.
Market Place
Axyntis, your smart and reliable partner for CDMO services and generic APIs.
